Evidence map›Paper›PMID 29769197›Full record

ArticleCancer research2018

Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Dhruv Kumar, Jacob New, Vikalp Vishwakarma, Radhika Joshi, Jonathan Enders, Fangchen Lin, Sumana Dasari, Wade R Gutierrez, George Leef, Sivapriya Ponnurangam and 14 more

Abstract read
In one paragraph

Article in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. FGFR Inhibitor AZD4547 Disrupts Inflammatory CAF Crosstalk With Cancer Cells and Macrophages and Attenuates Metastasis in Pancreatic Cancer.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Targeting CAF-specific metabolic pathways in breast cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 1 country.

Dhruv Kumar *Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.ORCID 0000-0003-2586-9397
Jacob New *Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Vikalp Vishwakarma *Department of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.ORCID 0000-0001-5555-2126
Radhika JoshiDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Jonathan EndersDepartment of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas.
Fangchen LinDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Sumana DasariDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Wade R GutierrezDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
George LeefDepartment of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Sivapriya PonnurangamDepartment of Surgery, University of Kansas Medical Center, Kansas City, Kansas.
Hemantkumar ChavanDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Lydia GanadenDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Mackenzie M ThorntonDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Hongying DaiHealth Services & Outcomes Research, Children's Mercy Hospital, Kansas City, Missouri.
Ossama TawfikDepartment of Pathology, University of Kansas Medical Center, Kansas City, Kansas.
Jeffrey StraubDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Yelizaveta ShnayderDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Kiran KakaralaDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Terance Ted TsueDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Douglas A GirodDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas.
Bennett Van HoutenDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Shrikant AnantDepartment of Surgery, University of Kansas Medical Center, Kansas City, Kansas.
Partha KrishnamurthyDepartment of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Sufi Mary ThomasDepartment of Otolaryngology, University of Kansas Medical Center, Kansas City, Kansas. sthomas7@kumc.edu.
University of Kansas Medical Center · USUniversity of Pittsburgh · USThe University of Kansas Cancer Center · USChildren's Mercy Hospital · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI COPPLE, BRYAN L · 2006 to 2011
$12.1M
Nuclear Receptors in Liver Health and DiseaseP20GM103549 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2012 to 2015
$8.1M
Pilot Grants ProgramP30GM118247 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2016 to 2020
$5.5M
Bitter Melon Component and Colon Cancer PreventionR01CA190291 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ANANT, SHRIKANT, UMAR, SHAHID · 2014 to 2018
$2.7M
ROS driven mitochondrial-telomere dysfunction during environmental stressR33ES025606 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L, VAN HOUTEN, BENNETT · 2017 to 2019
$1.6M
NCI NIH HHS P30 CA047904NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA190291NCRR NIH HHS P20 RR021940NIEHS NIH HHS R33 ES025606NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P20 GM103549NIGMS NIH HHS P30 GM118247
6 · The paper itself

Abstract

Despite aggressive therapies, head and neck squamous cell carcinoma (HNSCC) is associated with a less than 50% 5-year survival rate. Late-stage HNSCC frequently consists of up to 80% cancer-associated fibroblasts (CAF). We previously reported that CAF-secreted HGF facilitates HNSCC progression; however, very little is known about the role of CAFs in HNSCC metabolism. Here, we demonstrate that CAF-secreted HGF increases extracellular lactate levels in HNSCC via upregulation of glycolysis. CAF-secreted HGF induced basic FGF (bFGF) secretion from HNSCC. CAFs were more efficient than HNSCC in using lactate as a carbon source. HNSCC-secreted bFGF increased mitochondrial oxidative phosphorylation and HGF secretion from CAFs. Combined inhibition of c-Met and FGFR significantly inhibited CAF-induced HNSCC growth

Indexed as

AnimalsCancer-Associated FibroblastsCell Line, TumorCell MovementDisease ProgressionGlycolysisHead and Neck NeoplasmsHumansMiceMice, NudeOxidative PhosphorylationProto-Oncogene Proteins c-metReceptor Protein-Tyrosine KinasesSignal TransductionSquamous Cell Carcinoma of Head and NeckUp-RegulationProto-Oncogene Proteins c-metReceptor Protein-Tyrosine Kinases

Identifiers

PMID29769197
PMCPMC6050074
OpenAlexW2804989146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.